Case Study: iQure Pharma achieves a single source of truth for cap table management with Carta

iQure Pharma - Customer Case Study

iQure Pharma, a Princeton-based biotech developing therapies for neurodegenerative diseases, faced challenges managing its cap table and shareholder communications from an internal system while progressing from pre-seed into institutional fundraising. To address this, iQure moved its cap table to Carta to centralize ownership records and improve shareholder access and communication.

Carta delivered a proactive, solution-focused onboarding—reconciling historical convertible note data and ensuring all prior records were imported accurately with hands-on support from an implementation manager. As a result, iQure now has one source of truth for its cap table, smoother fundraising processes, and clearer shareholder access and communication thanks to Carta’s implementation.

iQure Pharma

Pawel Zolnierczyk

Chief Executive